US biotech firm Regeneron-
By AFP WASHINGTON: US biotech firm Regeneron said Tuesday that its synthetic antibody treatment for Covid-19 may be less effective […]
By AFP WASHINGTON: US biotech firm Regeneron said Tuesday that its synthetic antibody treatment for Covid-19 may be less effective […]
By ANI NEW DELHI: Commenting on the study of the Lancet Infectious Diseases on the effectiveness of COVAXIN (BBV152) against
By PTI NEW DELHI: The ideal time for a booster dose for COVID-19 vaccine is six months after the second
The UN health agency on Wednesday issued an emergency use listing (EUL) for Covaxin developed by Bharat Biotech, adding to
By PTI UNITED NATIONS: The World Health Organisation’s technical advisory group on Tuesday sought “additional clarifications” from Bharat Biotech for
Hyderabad-based Bharat Biotech, which has developed Covaxin, had submitted EOI (Expression of Interest) to the World Health Organisation on April
Express News Service BENGALURU: Bharat Biotech, the developer of the indigenously developed Covid-19 vaccine Covaxin, is said to have submitted